Broadfin Capital, LLC and 2 Others Exercises Options at Biodelivery Sciences International Inc (BDSI) — SEC Form 4, Aug 10, 2021
SEC Form 4 · No Market Transaction
Option Exercise
Derivative exercise — no open market transaction.
Reporting Owners
Director
Director
Director
TXN 2021-08-10
·
FILED 2021-08-10
Equity Position
4.7M sh
4,655,689 → 4,700,689
Equity Change
+1.0%
shares held after vs before
Filing Lag
0 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owners
| Name | Relationship |
|---|---|
| Broadfin Capital, LLC CIK 0001511901 |
Director
|
| Kevin Kotler CIK 0001601692 |
Director
|
| Broadfin Healthcare Master Fund Ltd CIK 0001511900 |
Director
|
Broadfin Capital, LLC at Biodelivery Sciences International Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Biodelivery Sciences International Inc
| 2022-03-22 | Gift/Other | — | View |
| 2022-02-15 | - | — | View |
| 2022-01-31 | Exercise | — | View |
| 2021-11-22 | Buy | +$306,000 | View |
| 2021-11-15 | Buy | +$320,000 | View |
Non-Derivative Securities Transactions
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1F2F3 | $0.00 | 2021-08-06 | M - Exercise | 30,000 D | $0.00 | 2022-08-01 | 30,000 Common Stock | Indirect |
| Stock Options (right to buy)F4F2F3 | $2.93 | 2021-08-10 | C - Conversion | 15,000 A | $2.93 | 2028-07-31 | 15,000 Common Stock | Indirect |
Footnotes (4)
- F1
- The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units ("RSUs") granted to the Reporting Person on August 1, 2018 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs vest as follows: 15,000 RSUs vest in the first open window following the Company's 2022 Annual Meeting of Stockholders. Show more
- F2
- 300,000 shares of Common Stock are held in the account of Broadfin Holdings, LLC., a private investment fund, and are deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Holdings, LLC. Show more
- F3
- 4,400,689 shares of Common Stock are held in the account of Broadfin Healthcare Master Fund, Ltd., a private investment fund managed by Broadfin Capital, LLC, and may be deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Capital, LLC. Broadfin Healthcare Master Fund, Ltd., Broadfin Capital, LLC, and Kevin Kotler affirmatively (i) disclaim beneficial ownership of the reportable securities, (ii) states that this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 ("Section 16") of the Securities Exchange Act of 1934, as amended (the "Act") or any other purpose, except to the extent of their pecuniary interest therein, and (iii) disclaim being a "group" for purposes of Section 16. Show more
- F4
- The shares of common stock were acquired by the Reporting Person as a result of the exercise of stock options granted to the Reporting Person on August 1, 2018 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining options vest as follows: 7,500 options vest in the first open window following the Company's 2022 Annual Meeting of Stockholders. Show more
Related filings at Biodelivery Sciences International Inc
Other insiders at Biodelivery Sciences International Inc
GET /v1/forms/4/0001103021-21-000072
API docs
View Original SEC Filing